Noticias de DARE_US

Noticias del mercado

Últimas noticias sobre DARE_US — 61 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: DARE_US ✕ 61 resultados
26/03/2026 DARE_US — Stock Titan
Daré takes women's arousal cream to all 50 states ahead of Q2 sales
26/03/2026 DARE_US — Yahoo Finance
Dare Bioscience, Inc. (DARE) Reports Q4 Loss, Lags Revenue Estimates
26/03/2026 DARE_US — TradingView
Dare Bioscience Inc reports results for the quarter ended December 31 - Earnings Summary
26/03/2026 DARE_US — Stock Titan
Daré Bioscience (NASDAQ: DARE) details 2025 loss, funding boost and upcoming product launches
26/03/2026 DARE_US — Seeking Alpha
Daré Bioscience, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:DARE) 2026-03-26
26/03/2026 DARE_US — Investing.com
Earnings call transcript: Daré Bioscience Q4 2025 highlights capital efficiency
26/03/2026 DARE_US — Stock Titan ES ← EN
Daré Bioscience (NASDAQ: DARE) amplía el modelo de salud de la mujer de doble vía
26/03/2026 DARE_US — MarketBeat
Dare Bioscience Q4 2025 Earnings Call Transcript
25/03/2026 DARE_US — GuruFocus
Dare Bioscience Inc (DARE) Q4 2025 Earnings Report Preview: What To Expect
23/03/2026 DARE_US — Stock Titan
A Viagra ingredient is now in a topical cream developed for women
23/03/2026 DARE_US — ChartMill
On National Viagra Day, Women Finally Claim Their Turn:
19/03/2026 DARE_US — Minichart
DARE BIOSCIENCE, INC. Files Form 8-K with SEC Reporting Unregistered Sale of Equity Securities
17/03/2026 DARE_US — Investing.com
Dare Bioscience completes closing of Regulation A equity offering
17/03/2026 DARE_US — Stock Titan
Daré Bioscience (DARE) issues 43,050 preferred-and-warrant units
16/03/2026 DARE_US — GuruFocus
Dare Bioscience (DARE) Advances Investigational Preterm Birth Tr
16/03/2026 DARE_US — Stock Titan
NIH funds hormone ring as preterm birth lacks FDA-approved treatment
16/03/2026 DARE_US — GuruFocus
Dare Bioscience (DARE) Advances Investigational Preterm Birth Tr
12/03/2026 DARE_US — Stock Titan
Persistent HPV has no FDA-approved drug; Daré CEO lays out DARE-HPV trial plan
02/03/2026 DARE_US — Stock Titan
Daré Bioscience (NASDAQ: DARE) updates investor presentation and furnishes 8-K
28/02/2026 DARE_US — Intellectia AI
DARE Should I Buy

Página 3 de 4

keyboard_arrow_up